December 1, 2014
By Riley McDermid, BioSpace.com Breaking News Sr. Editor
The competition for the title of Best Hair in Biopharma added another chapter Monday, after Celgene ‘s Vice President of Investor Relations Patrick Flanigan was named by an analyst as a top contender for the prize.
Analyst Mark Schoenebaum, a biotech and pharmaceuticals analyst and medical doctor for ISI Group, wrote in a note this week that Flanigan’s chances are “increasingly competitive” with Bristol-Myers Squibb Company ‘s John Elicker and Acorda Therapeutics ‘s Ron Cohen.
“As was widely expected by the Street, Patrick’s hair was beautifully coiffured,” wrote Schoenebaum in a note to investors. However, Flanigan could up his chances by using styling products, estimated the analyst.
“Interestingly, I was able to confirm that he, indeed, uses no product,” he said. “The Street is likely to increase Patrick’s chances of winning my ‘best hair’ award should he initiate product use.”
